Product Code: GVR-4-68040-558-6
Pet Bird Health Market Growth & Trends:
The global pet bird health market size is expected to reach USD 1.50 billion by 2030, registering a CAGR of 8.03% from 2025 to 2030, according to a new report by Grand View Research, Inc. The primary factors driving the growth of this market are the increasing prevalence of diseases among pet birds, the growing risk of zoonotic transfer of the diseases from pet birds to humans, and large-scale research projects undertaken by international animal welfare organizations and government entities of various countries playing a crucial role in these projects.
For instance, according to February 2025 reports from Edgerton Bird Sanctuary, extra precautions are being employed amid rising cases of bird flu to protect its pet birds and prevent the spread of the disease. Bird flu, specifically the highly pathogenic avian influenza A(H5N1), has been increasing across the U.S., with around 70 human cases reported since April 2024, mostly linked to exposure to infected poultry and dairy cows. While the risk to the general public remains low, the virus poses a moderate to high risk to those in close contact with infected animals.
Technological advances and strict biosecurity measures, including disinfection protocols and quarantine procedures, are being implemented at sanctuaries to safeguard birds. Telemedicine and remote monitoring also help manage bird health more effectively. Public health agencies are emphasizing responsible bird feeder management and reporting of affected or deceased birds to curb the spread. Studies suggest prior infection with seasonal flu may offer some protection against H5N1, but human-to-human transmission has not been observed. Overall, the sanctuary's efforts reflect broader national strategies to contain outbreaks and protect both wild and domestic bird populations.
Additionally, March 2024 reports from Europe suggest a surge in parrot fever (psittacosis) in the region. This outbreak has resulted in five deaths and affected nearly 100 people, with cases reported in Austria, Denmark, Germany, Sweden, and the Netherlands. The disease, caused by the bacterium Chlamydia psittaci, primarily spreads through contact with infected birds or inhalation of droppings and secretions, especially among pet bird owners, poultry workers, and veterinarians.
Although human-to-human transmission is rare, the outbreak has raised public health concerns due to increased cases since 2023, with some infections originating in domestic birds. Authorities have emphasized the importance of good hygiene, quarantine of suspected birds, and surveillance of wild bird populations to prevent further spread. The WHO and national health agencies are monitoring the situation, recommending increased awareness, testing, and infection control measures. The outbreak has heightened awareness about the importance of regular veterinary check-ups, quarantine protocols for new birds, and proper cage maintenance systems, driving market growth for companies offering comprehensive bird health solutions.
Understanding the crucial nature of zoonotic diseases, countries like India have launched research projects to better combat bird-to-human diseases. In April 2025, the Indian Council for Medical Research (ICMR) launched a study to detect zoonotic diseases that could be transmitted from birds to humans. The study will monitor human populations, migratory & pet bird species, and their environments in select bird sanctuaries and wetlands across Sikkim, Maharashtra, and Tamil Nadu. The goal is to develop a real-time surveillance model, using advanced tools like Next Generation Sequencing, to detect and diagnose diseases in bird sanctuary workers and nearby residents. This collaborative effort aims to establish an early warning system for zoonotic spillovers and enhance India's preparedness for future pandemics.
Pet Bird Health Market Report Highlights:
- Based on product, the pharmaceuticals segment held the largest revenue share of 58.1% in 2024. Pharmaceutical companies are expanding their bird-specific medication offerings-including antiparasitic treatments and nutritional supplements-driven by rising demand for advanced avian healthcare and a growing number of avian veterinarians. Innovations in drug delivery methods and prescription-based products are improving treatment effectiveness and accessibility for bird health issues
- Based on application, the bacterial infections segment held the largest revenue share of over 49% in 2024 and is also expected to grow at the fastest rate of more than 8% over the forecast period. Bacterial infections are common in pet birds, especially in young or immunocompromised ones, often resulting from poor nutrition or husbandry. The most frequent infections involve the gastrointestinal and respiratory systems and can become systemic.
- Based on the distribution channel, E-commerce is expected to grow at the fastest CAGR of 11.2% during the forecast period. E-commerce platforms have become a vital channel for accessing a diverse range of products tailored for exotic pets like companion birds. They offer pet owners the convenience of purchasing medications, cages, accessories, specialty foods, and nutritional supplements from home, especially beneficial for those with limited access to physical pet stores or veterinary services.
- Based on region, Asia Pacific is the fastest growing market with a growth rate of 9% over the forecast period. The region is experiencing a multitude of market activities like increasing penetration and scope of healthcare services for pet birds, rising prevalence of diseases in pet birds, launch of unique products for pet birds, market entries by globally prominent companies, etc.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources
- 1.3.4. Primary Research
- 1.4. Information/Data Analysis
- 1.5. Market Formulation & Visualization
- 1.6. Data Validation & Publishing
- 1.7. Model Details
- 1.7.1. Commodity flow analysis
- 1.7.2. Global Market: CAGR Calculation
- 1.8. List of Secondary Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Pet Birds Health Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Rising Adoption of Pet Birds
- 3.2.1.2. Increasing Prevalence of Diseases in Pet Birds
- 3.2.1.3. Increasing Research Efforts
- 3.2.1.4. Rising Occurrence of Zoonotic Diseases in Pet Birds
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Lack of specialized veterinary expertise
- 3.2.2.2. Concerns Related to Animal Cruelty
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenge Analysis
- 3.2.5. Industry Analysis - Porter's
- 3.2.5.1. Bargaining power of the suppliers
- 3.2.5.2. Bargaining power of the buyers
- 3.2.5.3. Threats of substitution
- 3.2.5.4. Threats from new entrants
- 3.2.5.5. Competitive rivalry
- 3.2.6. PESTEL Analysis
- 3.2.6.1. Political landscape
- 3.2.6.2. Economic and Social landscape
- 3.2.6.3. Technological landscape
- 3.3. Pricing Analysis
- 3.4. Regulatory framework
- 3.5. Estimated Bird Population By key countries, 2024
- 3.6. Key Pet Bird Statistics
Chapter 4. Pet Birds Health Market: By Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Pet Birds Health Market: By Product Movement Analysis, 2024 & 2030 (USD Million)
- 4.2.1. Pharmaceuticals
- 4.2.1.1. Pharmaceuticals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.1.2. Anti Parasitic
- 4.2.1.2.1. Anti Parasitic Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.1.3. Antibiotics
- 4.2.1.3.1. Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.1.4. Antifungal
- 4.2.1.4.1. Antifungal Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.1.5. Nutritional Supplements
- 4.2.1.5.1. Nutritional Supplements Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.2. Diagnostics
- 4.2.2.1. Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.2.2. Consumables, reagents and kits
- 4.2.2.2.1. Consumables, reagents, and kits Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.2.3. Instruments and devices
- 4.2.2.3.1. Instruments and devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.3. Others
- 4.2.3.1. Other Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Pet Birds Health Market: By Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Pet Birds Health Market: By Application Movement Analysis, 2024 & 2030 (USD Million)
- 5.2.1. Bacterial Infection
- 5.2.1.1. Bacterial Infection Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 5.2.2. Parasitic Infestations
- 5.2.2.1. Parasitic Infestations Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 5.2.3. Others
- 5.2.3.1. Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Pet Birds Health Market: By Distribution Channel Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Pet Birds Health Market: By Distribution Channel Movement Analysis, 2024 & 2030 (USD Million)
- 6.2.1. Veterinary Hospitals/ Clinics
- 6.2.1.1. Veterinary Hospital/ Clinics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.2. Retail
- 6.2.2.1. Retail Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.3. E-commerce
- 6.2.3.1. E-commerce Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Pet Birds Health Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Share Analysis, 2024 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Regional Market Snapshot
- 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 7.5. North America
- 7.5.1. U.S.
- 7.5.1.1. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.2. Canada
- 7.5.2.1. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.3. Mexico
- 7.5.3.1. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6. Europe
- 7.6.1. UK
- 7.6.1.1. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.2. Germany
- 7.6.2.1. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.3. France
- 7.6.3.1. France market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.4. Italy
- 7.6.4.1. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.5. Spain
- 7.6.5.1. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.6. Norway
- 7.6.6.1. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.7. Sweden
- 7.6.7.1. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.8. Denmark
- 7.6.8.1. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7. Asia Pacific
- 7.7.1. Japan
- 7.7.1.1. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.2. China
- 7.7.2.1. China market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.3. India
- 7.7.3.1. India market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.4. Australia
- 7.7.4.1. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.5. South Korea
- 7.7.5.1. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.6. Thailand
- 7.7.6.1. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8. Latin America
- 7.8.1. Brazil
- 7.8.1.1. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.2. Argentina
- 7.8.2.1. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9. MEA
- 7.9.1. South Africa
- 7.9.1.1. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.2. Saudi Arabia
- 7.9.2.1. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.3. UAE
- 7.9.3.1. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.4. Kuwait
- 7.9.4.1. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Company Participant Categorization
- 8.2. Company Market Position Analysis/ Heat Map Analysis
- 8.3. Company Profile
- 8.3.1. AdvaCare Pharma
- 8.3.1.1. Company overview
- 8.3.1.2. Financial performance
- 8.3.1.3. Product benchmarking
- 8.3.1.4. Strategic initiatives
- 8.3.2. Thermo Fisher Scientific Inc.
- 8.3.2.1. Company overview
- 8.3.2.2. Financial performance
- 8.3.2.3. Product benchmarking
- 8.3.2.4. Strategic initiatives
- 8.3.3. INDICAL BIOSCIENCE GmbH
- 8.3.3.1. Company overview
- 8.3.3.2. Financial performance
- 8.3.3.3. Product benchmarking
- 8.3.3.4. Strategic initiatives
- 8.3.4. Vetafarm
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. VioVet Ltd (Pethealth)
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. Zoetis
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. HomeoPet LLC.
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Vetnil
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. Merck & Co., Inc
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. Johnsons
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives
- 8.4. Strategy Mapping
- 8.4.1. Mergers & Acquisitions
- 8.4.2. Partnerships & Collaborations
- 8.4.3. Expansion
- 8.4.4. Product launch
- 8.4.5. Others
- 8.5. List of other Key players